+971 56 274 1787WhatsApp
Symptom

Health Information

Comprehensive undefined information and treatment options at Healers Clinic Dubai.

"You are not alone in this journey."

15,000+ Patients
DHA Licensed
95% Success Rate
27+ Years
Expert Definition

Understanding This Symptom

Medical Definition

Subject Matter Expert Verified

Osteoporosis is a metabolic bone disorder characterized by progressive loss of bone mineral density and deterioration of bone microarchitecture, making bones fragile and susceptible to fractures.

It occurs when the balance between bone formation (by osteoblasts) and bone resorption (by osteoclasts) tips toward net bone loss.

This results in T-scores of -2.

5 or lower on DEXA scans, affecting primarily the hip, spine, and wrist.

It affects over 200 million people worldwide, with post-menopausal women being at highest risk due to estrogen deficiency.

Quick Facts

Expert-reviewed by medical professionals
Based on current medical research
Updated for 2026 standards

Need More Information?

Our experts can provide personalized guidance

Book Consultation
Healthy State

What Optimal Health Looks Like

Understanding how your body functions when healthy helps identify dysfunction

Healthy bone is living tissue that undergoes constant remodeling through a precisely balanced cycle of formation and resorption.

Osteoblasts (bone-forming cells) synthesize new bone matrix and mineralize it, while osteoclasts (bone-resorbing cells) break down old or damaged bone.

In healthy adults, this remodeling maintains skeletal integrity with about 10% of the skeleton being remodeled annually.

The RANK/RANKL/OPG signaling pathway regulates osteoclast activity, while Wnt signaling, parathyroid hormone (PTH), and growth factors like IGF-1 stimulate osteoblast function.

Healthy Function

Your body is designed to maintain balance and self-regulate

Optimal Range
Development Process

How This Develops

1

Estrogen deficiency - Post-menopausal women experience rapid bone loss (

2

Calcium and vitamin D deficiency - Inadequate calcium intake leads to secondary hyperparathyroidism, where PTH increases bone resorption to maintain serum calcium levels; vitamin D deficiency impairs calcium absorption in the gut

3

Impaired osteoblast function - Aging, oxidative stress, chronic inflammation, and certain medications reduce osteoblast differentiation and activity

4

Cortisol excess - Chronic stress or Cushing's syndrome elevates cortisol, which directly stimulates osteoclastogenesis and inhibits osteoblast function

5

Chronic inflammation - Pro-inflammatory cytokines (IL-

6

Sedentary lifestyle - Weight-bearing exercise is essential for mechanical loading that stimulates bone formation; immobility leads to disuse osteoporosis

7

Medications - Glucocorticoids, proton pump inhibitors, aromatase inhibitors, and certain anticonvulsants impair bone formation or increase resorption

Understanding the mechanism helps us target the root cause rather than just treating symptoms.

Cost of Waiting

What Happens If Left Untreated

Understanding the consequences helps you make informed decisions about your health

Short-Term Consequences

Days to weeks

  • [object Object] | [object Object] | [object Object]

Time Matters

Don't wait for symptoms to worsen. Early intervention leads to better outcomes.

Common Questions

Frequently Asked Questions

Expertise Behind This Guide

Evidence-Based Information

Dr. Hafeel Afsar, DHA Licensed Integrative and Functional Medicine Practitioner Specialization: Bone metabolism, endocrine disorders, integrative approaches to osteoporosis Qualifications: Board-certified in Integrative Medicine, Advanced Hormone Therapy Training Experience: 15+ years treating metabolic bone disorders with integrative and functional medicine protocols

References & Further Reading

Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364-376. doi:10.1016/S0140-6736(18)32112-3 - Comprehensive review of osteoporosis pathophysiology, diagnosis, and management.
Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3-44. doi:10.1007/s00198-018-4704-5 - European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) clinical guidelines.
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. J Clin Endocrinol Metab. 2019;105(3):dgaa048 - Endocrine Society clinical practice guidelines.
Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381. doi:10.1007/s00198-014-2794-4 - National Osteoporosis Foundation guide.

This information is for educational purposes and not a substitute for professional medical advice.